Rachel K. King

Insider Reports History

Entity
Individual
Location
C/O Glycomimetics, Inc., 401 Professional Drive, Suite 250, Gaithersburg, MD
Signature
/s/Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rachel K. King:

Insider Reports Filed by Rachel K. King

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVAX NOVAVAX INC Dec 13, 2024 1 -$37.4K 4 Jan 2, 2025 Director
FULC Fulcrum Therapeutics, Inc. Nov 12, 2024 1 $0 4 Nov 14, 2024 Director
FULC Fulcrum Therapeutics, Inc. Nov 12, 2024 0 $0 3 Nov 14, 2024 Director
NVAX NOVAVAX INC Jun 12, 2024 4 $248K 4 Jun 14, 2024 Director
GLYC GLYCOMIMETICS INC May 1, 2024 1 $0 4 May 1, 2024 Director
GLYC GLYCOMIMETICS INC Dec 29, 2023 1 $10K 4 Jan 2, 2024 Director
GLYC GLYCOMIMETICS INC Sep 30, 2023 1 $10K 4 Oct 3, 2023 Director
NVAX NOVAVAX INC Jun 10, 2023 4 $0 4 Jun 13, 2023 Director
GLYC GLYCOMIMETICS INC May 19, 2023 1 $0 4 May 22, 2023 Director
GLYC GLYCOMIMETICS INC Mar 29, 2023 1 $10K 4 Apr 2, 2024 Director
GLYC GLYCOMIMETICS INC Dec 31, 2022 2 $0 5 Feb 6, 2023 Director
NVAX NOVAVAX INC Jun 17, 2022 2 $0 4 Jun 21, 2022 Director
NVAX NOVAVAX INC Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
GLYC GLYCOMIMETICS INC May 18, 2022 1 $0 4 May 20, 2022 Director
NVAX NOVAVAX INC Jun 25, 2021 2 $0 4/A Aug 20, 2021 Director
NVAX NOVAVAX INC Jun 17, 2021 2 $0 4 Jun 22, 2021 Director
NVAX NOVAVAX INC May 19, 2021 1 $97.7K 4 May 21, 2021 Director